Cargando…

Impact of immunohistochemistry-based molecular subtype on chemosensitivity and survival in Hispanic breast cancer patients following neoadjuvant chemotherapy

BACKGROUND: Neoadjuvant chemotherapy (NAC) is the standard treatment for patients with locally advanced breast cancer, showing improvement in disease-free survival (DFS) and overall survival (OS) rates in patients achieving pathological complete response (pCR). The relationship between immunohistoch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gómez, Rodolfo, Ossa, Carlos Andrés, Montoya, María Elvira, Echeverri, Carolina, Ángel, Gonzalo, Ascuntar, Johana, Borrero, Mauricio, Gil, Mónica, Herrera, Sabrina, Gutiérrez, Eduardo, Herazo, Fernando, Jiménez, Alejo, Madrid, Jorge, Reyes, Pedro Alejandro, Zuluaga, Lina, García, Héctor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cancer Intelligence 2015
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4544572/ https://www.ncbi.nlm.nih.gov/pubmed/26316883 http://dx.doi.org/10.3332/ecancer.2015.562

Ejemplares similares

Phyllodes tumor of the breast: a clinic-pathologic study of 77 cases in a Hispanic cohort
por: Ossa, Carlos Andres, et al.
Publicado: (2015)

Impact of Immunohistochemistry-Based Molecular Subtype on Chemosensitivity and Survival in Patients with Breast Cancer Following Neoadjuvant Chemotherapy
por: Yoo, Changhoon, et al.
Publicado: (2012)

Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response
por: Lips, E. H., et al.
Publicado: (2013)

Author’s response to letter “Antimicrobials administration time in patients with suspected sepsis: faster is better for severe patients”
por: Ascuntar, Johana, et al.
Publicado: (2020)

Antimicrobials administration time in patients with suspected sepsis: is faster better? An analysis by propensity score
por: Ascuntar, Johana, et al.
Publicado: (2020)

Community-acquired pneumonia: comparison of three mortality prediction scores in the emergency department
por: Hincapié, Carolina, et al.
Publicado: (2021)

Breast cancer in togolese women: immunohistochemistry subtypes
por: Adani-Ifè, Ablavi, et al.
Publicado: (2020)

Immunohistochemistry-Based Taxonomical Classification of Bladder Cancer Predicts Response to Neoadjuvant Chemotherapy
por: Font, Albert, et al.
Publicado: (2020)

Chemosensitivity Predicted by BluePrint 80-Gene Functional Subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST)
por: Whitworth, Pat, et al.
Publicado: (2014)

Subtyping of gliomas of various WHO grades by the application of immunohistochemistry
por: Popova, Svetlana N, et al.
Publicado: (2014)

Molecular subtyping of mammary Paget’s disease using immunohistochemistry
por: Arafah, Maria, et al.
Publicado: (2019)

Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular Subtyping
por: Whitworth, Pat, et al.
Publicado: (2016)

Association between site of infection and in-hospital mortality in patients with sepsis admitted to emergency departments of tertiary hospitals in Medellin, Colombia
por: Caraballo, César, et al.
Publicado: (2019)

Predictive molecular biomarkers for determining neoadjuvant chemosensitivity in muscle invasive bladder cancer
por: Murphy, Neal, et al.
Publicado: (2022)

Using immunohistochemistry to classify the molecular subtypes of Paget's disease of the breast
por: Cai, Yujiao, et al.
Publicado: (2023)

Molecular-based tumour subtypes of canine mammary carcinomas assessed by immunohistochemistry
por: Sassi, Francesco, et al.
Publicado: (2010)

Concordance of Immunohistochemistry-Based and Gene Expression-Based Subtyping in Breast Cancer
por: Holm, Johanna, et al.
Publicado: (2020)

Immunohistochemistry-derived subtypes of breast cancer distribution in four regions of Ethiopia
por: Belachew, Esmael Besufikad, et al.
Publicado: (2023)

CD133 Is a Useful Surrogate Marker for Predicting Chemosensitivity to Neoadjuvant Chemotherapy in Breast Cancer
por: Aomatsu, Naoki, et al.
Publicado: (2012)

Peripheral inflammation/immune indicators of chemosensitivity and prognosis in breast cancer patients treated with neoadjuvant chemotherapy
por: Qian, Yi, et al.
Publicado: (2018)

Differential prognostic value of MYC immunohistochemistry in subtypes of papillary renal cell carcinoma
por: Bellut, Julia, et al.
Publicado: (2017)

Presentation of the Molecular Subtypes of Breast Cancer Detected By Immunohistochemistry in Surgically Treated Patients
por: Kondov, Borislav, et al.
Publicado: (2018)

Exploring biomarkers for prognosis and neoadjuvant chemosensitivity in rectal cancer: Multi-omics and ctDNA sequencing collaboration
por: Jiang, Xiu-Feng, et al.
Publicado: (2022)

Markers of subtypes in inflammatory breast cancer studied by immunohistochemistry: Prominent expression of P-cadherin
por: Ben Hamida, Azza, et al.
Publicado: (2008)

Molecular portraits revealing the heterogeneity of breast tumor subtypes defined using immunohistochemistry markers
por: Dai, Xiaofeng, et al.
Publicado: (2015)

Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: implications for individualized therapy
por: Kim, Hyo Song, et al.
Publicado: (2016)

The Intratumoral Heterogeneity Reflects the Intertumoral Subtypes of Glioblastoma Multiforme: A Regional Immunohistochemistry Analysis
por: Bergmann, Natalie, et al.
Publicado: (2020)

Immunohistochemistry-based molecular subtyping of triple-negative breast cancer and its prognostic significance
por: Leeha, Marisa, et al.
Publicado: (2023)

Concordance of RT-qPCR with immunohistochemistry and its beneficial role in breast cancer subtyping
por: Li, Yilun, et al.
Publicado: (2023)

Prevalence of breast and ovarian cancer subtypes in Hispanic populations from Puerto Rico
por: Rodriguez-Velazquez, Ariel, et al.
Publicado: (2018)

Correlation between the molecular subtype of breast cancer and the in vitro adenosine triphosphate-based chemosensitivity assay
por: Chang, Jina, et al.
Publicado: (2013)

Response Prediction to Neoadjuvant Chemotherapy: Comparison between Pre-Therapeutic Gene Expression Profiles and In Vitro Chemosensitivity Assay
por: Singer, Christian F., et al.
Publicado: (2013)

Over expression of hRad9 protein correlates with reduced chemosensitivity in breast cancer with administration of neoadjuvant chemotherapy
por: Yun, Haiqin, et al.
Publicado: (2014)

High expression of TCN1 is a negative prognostic biomarker and can predict neoadjuvant chemosensitivity of colon cancer
por: Liu, Guang-jie, et al.
Publicado: (2020)

Clinical Application of Circulating Tumor Cells and Circulating Endothelial Cells in Predicting Bladder Cancer Prognosis and Neoadjuvant Chemosensitivity
por: Yang, Xiao, et al.
Publicado: (2022)

Distinct microbial communities that differ by race, stage, or breast-tumor subtype in breast tissues of non-Hispanic Black and non-Hispanic White women
por: Smith, Alana, et al.
Publicado: (2019)

Immunohistochemistry
por: HAWES, DEBRA, et al.
Publicado: (2009)

Anatomy, histochemistry, and immunohistochemistry of the olfactory subsystems in mice
por: Barrios, Arthur W., et al.
Publicado: (2014)

Biological subtyping of early breast cancer: a study comparing RT-qPCR with immunohistochemistry
por: Wirtz, Ralph M., et al.
Publicado: (2016)

The core four - A panel of immunohistochemistry markers to diagnose and subtype testicular germ cell tumors
por: Ranjitha, V. N., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3vphg6l8go2ijvlq8fjd5cevm1